QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Kuros Biosciences AG ("Kuros" or the "Company"), a leader in next generation bone graft technologies, notes th...

 checkmate-pharmaceuticals-q1-eps-073-down-from-065-yoy

Checkmate Pharmaceuticals (NASDAQ:CMPI) reported quarterly losses of $(0.73) per share. This is a 12.31 percent decrease over l...

 the-week-ahead-in-biotech-april-24-april-30-bristol-myers-squibb-supernus-hutchmed-axsome-coherus-fda-decisions-big-pharma-earnings-ipos-and-more

Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to...

 benzingas-top-ratings-upgrades-downgrades-for-april-20-2022

Upgrades

 btig-downgrades-checkmate-pharmaceuticals-to-neutral

BTIG analyst Kaveri Pohlman downgrades Checkmate Pharmaceuticals (NASDAQ:CMPI) from Buy to Neutral.

 54-biggest-movers-from-yesterday
54 Biggest Movers From Yesterday
04/20/2022 09:43:34

Gainers

 mid-afternoon-market-update-nasdaq-surges-200-points-dentsply-sirona-shares-plunge

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

 mid-day-market-update-crude-oil-down-over-5-checkmate-pharmaceuticals-shares-spike-higher

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

 38-stocks-moving-in-tuesdays-mid-day-session

Gainers

 mid-morning-market-update-markets-open-higher-dow-jumps-400-points

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 400 points on Tuesday.

 the-daily-biotech-pulse-regeneron-acquires-checkmate-pharma-modernas-bivalent-booster-covid-19-vaccine-update-priority-review-for-astrazenecas-enhertu

Here's a roundup of top developments in the biotech space over the last 24 hours.

 why-checkmate-pharmaceuticals-shares-are-skyrocketing

Checkmate Pharmaceuticals Inc (NASDAQ: CMPI) shares are trading higher by 328.40% to $10.41 during Tuesday's pre-market ses...

Core News & Articles

Proposed ~$250 million all-cash acquisition strengthens Regeneron's portfolio of diverse and combinable immuno-oncology can...

 the-daily-biotech-pulse-aeglea-stock-jumps-on-inherited-metabolic-disease-data-partial-hold-lifted-on-gileads-2-blood-trials-early-data-from-novartis-kras-inhibitor-and-more

Here's a roundup of top developments in the biotech space over the last 24 hours:

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION